As phase 3 trials come to an end for front runners Pfizer and Moderna, the companies may be seeking emergency use authorization from the FDA in about a month. Widespread availability of vaccines for the general public would not be expected until near mid-2021.

—

Send in a voice message: https://podcasters.spotify.com/pod/show/covidupdates/message